Skip to main content

DNLI

Denali Therapeutics Inc.

Company with tickers: DNLI

CIK
1714899
CUSIP
24823R105
Shares Outstanding
158,709,737
13F Activity (30d)
162 filings 160 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 270
Total Value: $2,846,926,527
Total Shares: 148,277,431
Showing 1–100 of 281 holdings by value · page 1 of 3

Institutional Ownership Trend

25 quarters

Holder Concentration

Across 270 13F filers · Δ vs Dec 31, 2025
Top Holder
8.8%
Jun 2023 → Mar 2026 · range 8.6% – 17.6%
+0.2 pts
Top 5
31.6%
Jun 2023 → Mar 2026 · range 31.6% – 53.5%
−3.0 pts
Top 10
49.0%
Jun 2023 → Mar 2026 · range 49.0% – 67.1%
−3.1 pts
HHI
340
Jun 2023 → Mar 2026 · range 340 – 718
Broadly held−40

Quarterly Activity

vs Dec 31, 2025
New
55
Increased
106
Decreased
57
Sold Out
35
Unchanged
52
Holder count: +20
Institutional value: +14.0%
Shares held: -2.0%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 281
Export CSV
Holder Value (USD) % of 13F Shares Open